Evidence map›Paper›PMID 43003909›Full record

ReviewNature reviews. Endocrinology2026

Hypothalamic astrocytes fine-tune the signals governing metabolism.

Julie A Chowen, Manuel Tena-Sempere, Laura M Frago, Tamas L Horvath, Jesús Argente

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Julie A ChowenDepartment of Endocrinology, Hospital Infantil Universitario Niño Jesús (HNJS), Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús (FIBHNJS), Madrid, Spain. julieann.chowen@salud.madrid.org.ORCID http://orcid.org/0000-0002-4770-2291
Manuel Tena-SempereCIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0002-4741-5567
Laura M FragoDepartment of Endocrinology, Hospital Infantil Universitario Niño Jesús (HNJS), Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús (FIBHNJS), Madrid, Spain.ORCID http://orcid.org/0000-0002-5927-9240
Tamas L HorvathProgram in Integrative Cell Signaling and Neurobiology of Metabolism, Department of Comparative Medicine, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-7522-4602
Jesús ArgenteDepartment of Endocrinology, Hospital Infantil Universitario Niño Jesús (HNJS), Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús (FIBHNJS), Madrid, Spain.ORCID http://orcid.org/0000-0001-5826-0276

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Astrocytes are known to have key roles in the neuroendocrine control of metabolism. The spectrum of actions of this cell population continues to expand as their heterogeneity is deciphered and new study approaches are employed. Astrocytes were first implicated in metabolic control when they were shown to participate in hypothalamic inflammation induced by high-fat diets, which leads to complications such as continued weight gain and glucose intolerance. In addition to their participation in pathophysiological processes associated with poor nutrition and obesity, these glial cells are now accepted as fundamental players in the physiological control of energy homeostasis. Along with their effect on neurons controlling appetite and energy expenditure, glial cells are implicitly involved in the generation of circadian rhythms, including eating and sleep patterns that affect metabolism and may link metabolism with other neuroendocrine systems such as puberty. The evolving concepts regarding astrocytes in metabolic control, including their participation in responses to currently used obesity drugs, highlight them as potential therapeutic targets. Here, we review advances in our understanding of how astrocytes participate in these processes, describe the mechanisms involved and discuss future directions.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.